LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.040
-0.070 (-6.30%)
Jul 18, 2025, 4:00 PM - Market closed
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $19.85 million as of July 18, 2025. Its market cap has decreased by -82.80% in one year.
Market Cap
19.85M
Enterprise Value
44.51M
1-Year Change
-82.80%
Ranking
Category
Stock Price
1.04
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $19.85M, a decrease of -91.29%. That is a compound annual growth rate of -46.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 21.18M | -67.92% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |